TNF Pharmaceuticals, Inc.
TNFA
$0.1228
-$0.0072-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.52% | -6.99% | 79.83% | 2.39% | -314.62% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -268.93% | 86.19% | -94.27% | -11.84% | 538.63% |
| Change in Net Operating Assets | -153.51% | 128.30% | -966.81% | -51.12% | -77.15% |
| Cash from Operations | -245.53% | 78.96% | -36.10% | -51.86% | 9.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.60% | -64.30% | 128.00% | -1,605.61% | -87.66% |
| Cash from Investing | 130.60% | -64.30% | 128.00% | -1,605.61% | -87.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 100.00% | 17.97% |
| Total Dividends Paid | -- | -- | -- | 100.00% | 11.26% |
| Other Financing Activities | -- | -- | -- | 100.00% | 11.67% |
| Cash from Financing | -- | -212.88% | -91.42% | 1,078.88% | 11.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.20% | -255.29% | 111.44% | 112.64% | -203.05% |